Superinvestor Tracker
← All Investors

Revolution Medicines Inc

RVMD

Holders

2

Combined Value

$31.32M

Combined Shares

322,060

Current Price

$153.87

52W High

$166.50

vs 52W High

−7.6%

Investor Activity Chart

Quarterly buys (▲) and sells (▼) by tracked investors. Click a marker to view that investor's portfolio; hover for details. Price line is implied from 13F filings (value ÷ shares), not market data.

Held By

Tracked investors currently holding this security, based on each investor's most recent 13F filing. Gain compares the current market price to each investor's estimated average buy price.

InvestorValue% of PortfolioAvg Buy PriceGainLast ActivityAs of
Stanley Druckenmiller - Duquesne Family Office$30.72M0.91%~$97.25+58.2%BUY Q1 2026Q1 2026
Jim Simons - Renaissance Technologies$603.0K0.00%~$97.25+58.2%BUY Q1 2026Q1 2026

Recent Activity

Latest position changes by tracked investors. Prices are estimates implied from 13F filings.

QuarterInvestorActionEst. ValueEst. Price
Q1 2026Stanley Druckenmiller - Duquesne Family OfficeNEW BUY+$30.72M~$97.25
Q1 2026Jim Simons - Renaissance TechnologiesNEW BUY+$603.0K~$97.25
Q4 2025Jim Simons - Renaissance TechnologiesSOLD OUT−$11.82M~$46.70
Q3 2025Jim Simons - Renaissance TechnologiesBUY+$448.3K~$46.70
Q2 2025Jim Simons - Renaissance TechnologiesBUY+$3.70M~$36.79
Q1 2025Jim Simons - Renaissance TechnologiesNEW BUY+$5.05M~$35.36

Ownership History

Aggregate position across all tracked investors per quarter (options excluded). Implied price is the reported value divided by shares held.

PeriodHoldersTotal SharesΔ SharesTotal ValueImplied Price
Q1 20262322,060+27.2%$31.32M$97.25
Q3 20251253,104+3.9%$11.82M$46.70
Q2 20251243,504+70.5%$8.96M$36.79
Q1 20251142,804$5.05M$35.36